知搜-全球专利检索

  1. 登录
  2. 注册

搜索结果

6 条记录 (耗时 0.021 秒)

    SUBSITUTED 2-(CHROMAN-6-YLOXYL)-THIAZOLES AND THEIR USE AS PHARMACEUTICALS
    1.
    发明申请
    SUBSITUTED 2-(CHROMAN-6-YLOXYL)-THIAZOLES AND THEIR USE AS PHARMACEUTICALS 审中-公开
    取代的2-（CHROMAN-6-YLOXYL）-THIAZOLES及其作为药物的用途

    公开(公告)号：US20140243292A1

    公开(公告)日：2014-08-28

    申请号：US14204220

    申请日：2014-03-11

    申请人： Sanofi

    发明人： Werngard CZECHTIZKY ,  John WESTON ,  Nils RACKELMANN ,  Michael PODESCHWA ,  Petra ARNDT ,  Klaus WIRTH ,  Heinz GOEGELEIN ,  Olaf RITZELER ,  Volker KRAFT ,  Patrice BELLEVERGUE ,  Gary McCORT

    IPC分类号： C07D417/12 ,  C07F9/6553 ,  C07D417/14

    CPC分类号： C07D417/12 ,  C07D417/14 ,  C07D471/04 ,  C07D487/04 ,  C07F9/655345

    摘要： The present invention relates to substituted 2-(chroman-6-yloxy)-thiazoles of the formula I, in which Ar, R2, R3 and R4 are as defined in the claims. The compounds of the formula I are inhibitors of the sodium-calcium exchanger (NCX), especially of the sodium-calcium exchanger of subtype 1 (NCX1), and are suitable for the treatment of diverse disorders in which intracellular calcium homeostasis is disturbed, such as arrhythmias, heart failure and stroke. The invention furthermore relates to processes for the preparation of the compounds of the formula I, their use as pharmaceuticals, and pharmaceutical compositions comprising them.

    摘要翻译： 本发明涉及式I的取代的2-（色满-6-基氧基） - 噻唑，其中Ar，R 2，R 3和R 4如权利要求中所定义。 式I的化合物是钠 - 钙交换剂（NCX）的抑制剂，特别是亚型1型（NCX1）的钠 - 钙交换剂的抑制剂，并且适用于治疗细胞内钙稳态受干扰的多种疾病，例如 作为心律失常，心力衰竭和中风。 本发明还涉及式I化合物的制备方法，它们作为药物的用途，以及包含它们的药物组合物。

    Substituted chroman-6-yloxy-cycloalkanes and their use as pharmaceuticals
    5.
    发明申请
    Substituted chroman-6-yloxy-cycloalkanes and their use as pharmaceuticals 有权
    取代的苯并二氢吡喃-6-基氧基 - 环烷烃及其作为药物的用途

    公开(公告)号：US20160016928A1

    公开(公告)日：2016-01-21

    申请号：US14772375

    申请日：2014-03-07

    申请人： SANOFI

    发明人： Werngard CZECHTIZKY ,  John WESTON ,  Nils RACKELMANN ,  Volker KRAFT ,  Petra ARNDT ,  Klaus WIRTH ,  Heinz GOEGELEIN ,  Olaf RITZELER

    IPC分类号： C07D311/60 ,  C07D407/14 ,  C07F9/655 ,  C07D405/12

    CPC分类号： C07D311/60 ,  C07D405/12 ,  C07D407/12 ,  C07D407/14 ,  C07D409/12 ,  C07D413/12 ,  C07D417/12 ,  C07D417/14 ,  C07F9/65522

    摘要： The present invention relates to substituted chroman-6-yloxy-cycloalkanes of the formula (I) in which Ar, R1 to R4, p and q are as defined in the claims. The compounds of the formula (I) are inhibitors of the sodium-calcium exchanger (NCX), especially of the sodium-calcium exchanger of subtype 1 (NCX1), and are suitable for the treatment of diverse disorders in which intracellular calcium homeostasis is disturbed, such as arrhythmias, heart failure and stroke. The invention furthermore relates to processes for the preparation of the compounds of the formula (I), their use as pharmaceuticals, and pharmaceutical compositions comprising them.

    摘要翻译： 本发明涉及式（I）的取代的苯并二氢吡喃-6-基氧基 - 环烷烃，其中Ar，R 1至R 4，p和q如权利要求中所定义。 式（I）的化合物是钠 - 钙交换剂（NCX）的抑制剂，特别是亚型1型（NCX1）的钠 - 钙交换剂的抑制剂，并且适用于治疗细胞内钙稳态受到干扰的多种疾病 ，如心律失常，心力衰竭和中风。 本发明还涉及制备式（I）化合物，其作为药物的用途以及包含它们的药物组合物的方法。